Pharmaleads
Immeuble Paris BioPark
11 Rue Watt
75013 PARIS
Tel: +33 (0)1 44 06 70 00
fax: +33 (0)1 44 06 60 99
CONTACTEZ-NOUS

PHARMALEADS substrates for BoNT quantification
PHARMALEADS at your service
PHARMALEADS and the FDA requirements
Aditionnal information on BoNTA substrates
PRICE of substrates for BoNT

On the development of the BoNTA specific PL50 and PL51 substrates

156AcIIGNLRHMALDMGNEIDTQNRQIDRIMEKADSNKTRIDEANNopRAPyaKNleLNH2203 (PL50)
                                  187AcSNKTRIDEANNopRAPyaKNleLNH2203  (PL63)

Botulinum toxin A exclusively cleaves SNAP25, a membrane protein involved in vesicle docking and neurotransmitter release.  Moreover, it cleaves this 206 amino-acid  protein at a single amide bond, Q197- R198 .
Based on the sequence of SNAP 25, we have designed specific BoNT/A substrates1,2

These results show that extending the PL63 peptide substrate to the α-exosite sequence significantly increases substrate binding, as suggested by Breidenbach and Brunger3, making both PL50 and PL51 the best available substrates on the market for BoNTA quantification.

1Fournie-Zaluski MC et al. (2005) PCT WO 2005121354                                              3Breidenbach & Brunger (2004) Nature, 432:925

2Poras H., Ouimet T., et al. (2009) AEM ,75 : 4382